Potential Immunotherapy Target TM4SF1
TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in...
Sep 05, 2022
CDH17: A Safe CAR-T Target for Treatment of Solid Tumors
Chimeric antigen receptor T cell (CAR-T) therapy has been successful in the field of hematological...
Jul 19, 2022
GDF15-GFRAL breaks into the new drug track
A variety of metabolic diseases that plague today's society, such as obesity, diabetes, cancer, etc.,...
Jul 12, 2022
The culprit of cancer metastasis - uPAR-uPA
Tumor invasion and metastasis are key risk factors for tumor recurrence and patient death. Tumor...
Jul 07, 2022
Visit KactusBio at TIDES2022 #634
TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio....
Apr 10, 2022
